Dipeptidyl Peptidase-4 Inhibitors May Reduce the Risk of Major Adverse Cardiovascular Events and All-cause Mortality In Patients With Type 2 Diabetes: Meta-analyses Oof Randomized Controlled Trials Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Sun, Xin
  • Hazzan, Afeez A
  • Bala, Malgorzata
  • Russe, Jason W
  • Johnston, Bradley
  • Carrasco-Labra, Alonso
  • Jankowski, Milosz
  • Neumann, Ignacio
  • Ferreira-Gonzalez, Ignacio
  • Fernandez-Balsells, Merce
  • Rios, Lorena
  • Bassler, Dirk
  • Briel, Matthias
  • Lopes, Luciane
  • Nordmann, Alain
  • Tikkinen, Kari A
  • Ismaila, Nofisat
  • Zhou, Qi
  • Mukherjee, Jayanti
  • Frederich, Robert
  • Iqbal, Nayyar
  • Walter, Stephen
  • Guyatt, Gordon

publication date

  • November 20, 2012